1 |
Hernández-Jiménez T, Cruz-Nova P, Ancira-Cortez A, Gibbens-Bandala B, Lara-Almazán N, Ocampo-García B, Santos-Cuevas C, Morales-Avila E, Ferro-Flores G. Toxicity Assessment of [(177)Lu]Lu-iFAP/iPSMA Nanoparticles Prepared under GMP-Compliant Radiopharmaceutical Processes. Nanomaterials (Basel) 2022;12. [PMID: 36500804 DOI: 10.3390/nano12234181] [Reference Citation Analysis]
|
2 |
Salvanou E, Kolokithas-ntoukas A, Liolios C, Xanthopoulos S, Paravatou-petsotas M, Tsoukalas C, Avgoustakis K, Bouziotis P. Preliminary Evaluation of Iron Oxide Nanoparticles Radiolabeled with 68Ga and 177Lu as Potential Theranostic Agents. Nanomaterials 2022;12:2490. [DOI: 10.3390/nano12142490] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
3 |
Cruz-nova P, Ancira-cortez A, Ferro-flores G, Ocampo-garcía B, Gibbens-bandala B. Controlled-Release Nanosystems with a Dual Function of Targeted Therapy and Radiotherapy in Colorectal Cancer. Pharmaceutics 2022;14:1095. [DOI: 10.3390/pharmaceutics14051095] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
4 |
Coria-domínguez L, Vallejo-armenta P, Luna-gutiérrez M, Ocampo-garcía B, Gibbens-bandala B, García-pérez F, Ramírez-nava G, Santos-cuevas C, Ferro-flores G. [99mTc]Tc-iFAP Radioligand for SPECT/CT Imaging of the Tumor Microenvironment: Kinetics, Radiation Dosimetry, and Imaging in Patients. Pharmaceuticals 2022;15:590. [DOI: 10.3390/ph15050590] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|